Malcolm Hoffman
Stock Analyst at BMO Capital
(1.01)
# 3,958
Out of 4,692 analysts
7
Total ratings
33.3%
Success rate
-6.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Malcolm Hoffman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACAD ACADIA Pharmaceuticals | Maintained: Buy | $36 | $29.65 | +21.42% | 2 | Aug 25, 2026 | |
| MPLT MapLight Therapeutics | Maintained: Buy | $46 → $20 | $11.36 | +76.06% | 2 | Aug 13, 2026 | |
| AXSM Axsome Therapeutics | Maintained: Buy | $310 | $205.40 | +50.93% | 2 | Aug 10, 2026 | |
| LBRX LB Pharmaceuticals | Initiated Coverage: Buy | $46 | $48.21 | -4.58% | 1 | Jul 21, 2026 |
ACADIA Pharmaceuticals
Aug 25, 2026
Maintained: Buy
Price Target: $36
Current: $29.65
Upside: +21.42%
MapLight Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $46 → $20
Current: $11.36
Upside: +76.06%
Axsome Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $310
Current: $205.40
Upside: +50.93%
LB Pharmaceuticals
Jul 21, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $48.21
Upside: -4.58%